BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6806932)

  • 1. The binding of purified factor VIII/von Willebrand factor to collagens of differing type and form.
    Scott DM; Griffin B; Pepper DS; Barnes MJ
    Thromb Res; 1981 Dec 1-15; 24(5-6):467-72. PubMed ID: 6806932
    [No Abstract]   [Full Text] [Related]  

  • 2. Identical binding site on human platelets for von Willebrand factor and bovine platelet aggregating factor.
    Suzuki K; Nishioka J; Hashimoto S
    Thromb Res; 1980 Jan 1-15; 17(1-2):215-23. PubMed ID: 6769177
    [No Abstract]   [Full Text] [Related]  

  • 3. Adsorption of von Willebrand factor/factor VIII by the genetically distinct interstitial collagens.
    Santoro SA
    Thromb Res; 1981 Mar; 21(6):689-91. PubMed ID: 6791300
    [No Abstract]   [Full Text] [Related]  

  • 4. Preferential binding of high molecular weight forms of von Willebrand factor to fibrillar collagen.
    Santoro SA
    Biochim Biophys Acta; 1983 Mar; 756(1):123-6. PubMed ID: 6402037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of succinylation and dodecyl, succinylation on bovine factor VIII/von Willebrand factor complex.
    Thuy LP; Brown JE; Baugh RF; Hougie C
    Thromb Res; 1980 May 1-15; 18(3-4):305-13. PubMed ID: 6774433
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of exercise on F VIII-complex: proportional increase of ristocetin cofactor (Von Willebrand factor) and F VIII-AGN, but disproportional increase of F VIII-AHF.
    Stibbe J
    Thromb Res; 1977 Jan; 10(1):163-8. PubMed ID: 300513
    [No Abstract]   [Full Text] [Related]  

  • 7. Proceedings: Interaction of ristocetin (R), von Willebrand factor (vWF), factor VIII clotting activity (VIIIc) and platelets.
    Zucker MB; McPherson J; Kim SJ; Macdonald VE; Taylor D; Johnson AJ; Barlow GH
    Thromb Diath Haemorrh; 1975 Nov; 34(2):582. PubMed ID: 1081748
    [No Abstract]   [Full Text] [Related]  

  • 8. Role of factor VIII-von Willebrand factor and fibronectin in the interaction of platelets in flowing blood with monomeric and fibrillar human collagen types I and III.
    Houdijk WP; Sakariassen KS; Nievelstein PF; Sixma JJ
    J Clin Invest; 1985 Feb; 75(2):531-40. PubMed ID: 3919060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of exercise on the factor VIII complex: a correlation of the Von Willebrand antigen and factor VIII coagulant antigen increase.
    Brown JE; Baugh RF; Hougie C
    Thromb Res; 1979; 15(1-2):61-7. PubMed ID: 314688
    [No Abstract]   [Full Text] [Related]  

  • 10. Factor VIII/von Willebrand protein. Modification of its carbohydrate causes reduced binding to platelets.
    Kao KJ; Pizzo SV; McKee PA
    J Biol Chem; 1980 Nov; 255(21):10134-9. PubMed ID: 6776109
    [No Abstract]   [Full Text] [Related]  

  • 11. Interaction of factor VIII-von Willebrand Factor with phospholipid vesicles.
    Andersson LO; Brown JE
    Biochem J; 1981 Oct; 200(1):161-7. PubMed ID: 6800356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Increased von Willebrand activity of low molecular-weight factor VIII following binding to gold granules].
    Furlan M; Perret BA; Beck EA
    Schweiz Med Wochenschr; 1980 Oct; 110(40):1456-8. PubMed ID: 6792697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasmin digestion of factor VIII: characterization of the breakdown products with respect to antigenicity and von Willebrand activity.
    Guisasola JA; Cockburn CG; Hardisty RM
    Thromb Haemost; 1978 Oct; 40(2):302-15. PubMed ID: 153594
    [No Abstract]   [Full Text] [Related]  

  • 14. Reactions of thrombin with human factor VIII/von Willebrande factor protein.
    Switzer ME; McKee PA
    J Biol Chem; 1980 Nov; 255(22):10606-11. PubMed ID: 6776120
    [No Abstract]   [Full Text] [Related]  

  • 15. Von Willebrand protein binds to extracellular matrices independently of collagen.
    Wagner DD; Urban-Pickering M; Marder VJ
    Proc Natl Acad Sci U S A; 1984 Jan; 81(2):471-5. PubMed ID: 6320190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteolytic activity of alpha 2-macroglobulin-enzyme complexes toward human factor VIII/von Willebrand factor.
    Switzer ME; Gordon HJ; McKee PA
    Biochemistry; 1983 Mar; 22(6):1437-44. PubMed ID: 6188490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exercise-induced changes of Factor VIII complex in healthy subjects and in type-I diabetics: relation between growth hormone and Von Willebrand Factor increments.
    Trovati M; Tamponi G; Marra S; Lorenzati R; Schinco P; Bazzan M; Vitali S; Cavalot F; Pagano G; Lenti G
    Horm Metab Res; 1983 Jul; 15(7):316-20. PubMed ID: 6411576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adhesion of human platelets to purified solid-phase von Willebrand factor: studies of normal and Bernard-Soulier platelets.
    Olson JD; Moake JL; Collins MF; Michael BS
    Thromb Res; 1983 Oct; 32(2):115-22. PubMed ID: 6419373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factor VIII/von Willebrand factor in glomerular nephropathies.
    Coppola R; Guerra L; Ruggeri ZM; Tarantino A; Mannucci PM; Ponticelli C
    Clin Nephrol; 1981 Nov; 16(5):217-22. PubMed ID: 6796318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response of factor VIII/von Willebrand factor to DDAVP in healthy subjects and patients with haemophilia A and von Willebrand's disease.
    Mannucci PM; Canciani MT; Rota L; Donovan BS
    Br J Haematol; 1981 Feb; 47(2):283-93. PubMed ID: 6781527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.